I-Flow gets US patent for Voicelink:
This article was originally published in Clinica
Executive Summary
I-Flow has been awarded a US patent for its Voicelink remote programmable infusion therapy system. The system allows remote monitoring and programming of intravenous infusion pumps via a touch tone telephone. The combination of Voicelink and the company's Verifuse Plus infusion pump provides a tamper-proof system that prevents a patient from accidentally or intentionally changing therapy. I-Flow, based in Irvine, California, has approximately 700 Voicelink systems installed in the US.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.